Yangtze River Pharmaceutical Group

Yangtze River Pharmaceutical Group, established in 1971, operates as a prominent innovative enterprise within the pharmaceutical and healthcare sectors. Recognized by the Ministry of Science and Technology in China, the organization maintains a robust operational footprint with over 18,000 employees and a diverse portfolio spanning traditional Chinese medicine, Western pharmaceuticals, and advanced medical devices. The company leverages its extensive R&D capabilities to deliver high-quality healthcare solutions, maintaining a presence in over 30 international markets.

The firm manages a complex supply chain and distribution network, with primary operations centered in Taizhou, Jiangsu, and additional subsidiaries strategically located in major hubs including Beijing, Shanghai, and Guangzhou. This infrastructure supports the production and global export of specialized health products, ensuring compliance with international standards while driving continuous innovation in therapeutic development. Meet Yangtze River Pharmaceutical Group's team to understand the organizational structure and leadership driving these technical advancements.

With a focus on social responsibility and clinical efficacy, the company continues to expand its influence in the Asia-Pacific region. By integrating traditional methodologies with modern pharmaceutical manufacturing, Yangtze River Pharmaceutical Group maintains a competitive position in the global market. The firm remains dedicated to scaling its production capacity and enhancing its product pipeline to meet evolving healthcare demands, consistently prioritizing scientific rigor and operational excellence across all business units to sustain long-term growth and industry leadership.